Literature DB >> 3512878

Donor availability as the primary determinant of the future of heart transplantation.

R W Evans, D L Manninen, L P Garrison, A M Maier.   

Abstract

Heart transplantation has now achieved a therapeutic status similar to that of cadaveric renal transplantation. Depending on patient selection criteria, it is estimated that as many as 15,000 people per year could conceivably benefit from a heart transplant, but the actual number of persons who will benefit is severely constrained by donor supply. Availability of heart donors was estimated based on data obtained on 1,955 organ donors in the United States. The results show that because of age and other contraindications, only 400 to 1,100 viable donor hearts may be available each year. Donor supply is the most critical determinant of the future of heart transplantation since it will dictate the number of transplants performed, the survival of transplant recipients, the total program expenditures associated with heart transplantation, the nature of the legal and ethical issues involved, the number of cardiac transplant programs required to make optimal use of the available donor hearts, and the future role of mechanical circulatory support systems.

Entities:  

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Year:  1986        PMID: 3512878

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Respect for donor choice and the Uniform Anatomical Gift Act.

Authors:  W Edinger
Journal:  J Med Humanit       Date:  1990

Review 2.  Radionuclide techniques for the assessment of myocardial viability and hibernation.

Authors:  J J Bax; E E van der Wall; M Harbinson
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

3.  Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system.

Authors:  O H Frazier; E A Rose; P McCarthy; N A Burton; A Tector; H Levin; H L Kayne; V L Poirier; K A Dasse
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

4.  Transplantation.

Authors:  Thomas E Starzl
Journal:  JAMA       Date:  1986-10-17       Impact factor: 56.272

Review 5.  Cardiac transplantation. Selection, immunosuppression, and survival.

Authors:  L W Stevenson; H Laks; P I Terasaki; B D Kahan; D C Drinkwater
Journal:  West J Med       Date:  1988-11

6.  Artificial hearts.

Authors:  T R Graham; C T Lewis
Journal:  BMJ       Date:  1989-04-01

7.  Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy.

Authors:  I L Kron; T L Flanagan; L H Blackbourne; R A Schroeder; S P Nolan
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

Review 8.  Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction.

Authors:  F A Mitropoulos; J A Elefteriades
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

9.  The first 20 years of heart transplantation in Ireland.

Authors:  D G Healy; M T Akbar; N Baktiari; J J Egan; N Mahon; D Veerasingam; J McCarthy; J Hurley; M Neligan; A E Wood
Journal:  Ir J Med Sci       Date:  2006 Jan-Mar       Impact factor: 1.568

10.  Cadaveric organ donation: ethical considerations for a new approach.

Authors:  I Kleinman; F H Lowy
Journal:  CMAJ       Date:  1989-07-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.